Back
Cadrenal Therapeutics 10K Form
Sell
26
CVKD
Cadrenal Therapeutics
Last Price:
0.41
Seasonality Move:
-45.93%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CVKD News And Ratings
See the #1 stock for the next 7 days that we like better than CVKD
CVKD Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-1.84M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.39 |
| Price / Book: | 1.06 |
Profitability
| EPS (TTM): | -0.31000 |
|---|---|
| Net Income (TTM): | $-4.85M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Cadrenal Therapeutics Earnings Forecast
Key Cadrenal Therapeutics Financial Ratios
- The Interest Expense is -0.20% of Operating Income.
- Per Share Earnings over the last 1 years have been positive in 0 years.
Cadrenal Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | CVKD |
| Website: | cadrenal.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CVKD Technical Analysis vs Fundamental Analysis
Sell
26
Cadrenal Therapeutics (CVKD)
is a Sell
Is Cadrenal Therapeutics a Buy or a Sell?
-
Cadrenal Therapeutics stock is rated a Sell
The current Cadrenal Therapeutics [CVKD] share price is $0.41. The Score for CVKD is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.